PoliticalRepoPoliticalRepo

Subjects

Healthcare

3,745 records · 14,444 documents

Also searched as: gezondheidszorg, health, health care, healthcare, public health, volksgezondheid, zorg, zorgstelsel

Records

Bill· SS. 545 (119th)open

Combating Illicit Xylazine Act

United States · United States Congress · 12 February 2025

Combating Illicit Xylazine Act This bill regulates xylazine under the Controlled Substances Act (CSA). Xylazine, also known as tranq , is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine. This bill adds xylazine, including its salts, isomers, and salts of isomers, to schedule III of the CSA. Schedule III controlled substances, including anabolic steroids, buprenorphine, and ketamine, have less potential for abuse than a schedule I or II substance, have a currently accepted medical use, and have low or moderate risk of dependence if abused. Under the bill, manufacturing, distributing, or dispensing xylazine, or possessing with intent to manufacture, distribute, or dispense xylazine for illicit use is subject to criminal penalties under the CSA. The bill also requires xylazine transactions to be tracked in the drug reporting system maintained by the DEA. The bill exempts from registration under the CSA persons and entities that possess xylazine (1) lawfully dispensed by a veterinarian or pharmacy and (2) for an animal or for use in certain animal-control or wildlife programs. The bill also exempts xylazine manufacturers from the CSA's physical security requirements. Finally, the bill requires the DEA, in coordination with the Department of Health and Human Services (HHS), to provide Congress with a report on how the agencies previously determined whether xylazine should be a controlled substance, including the full text of HHS's recommendations to the DEA for scheduling xylazine.

Bill· HRH.R. 3747 (119th)referred

Accelerating Access to Dementia and Alzheimer’s Provider Training Act

United States · United States Congress · 5 June 2025

Accelerating Access to Dementia and Alzheimer’s Provider Training Act or the AADAPT Act This bill reauthorizes through FY2031 and revises the Technology-enabled Collaborative Learning Program, which is administered by the Health Resources and Services Administration. This program provides grants to support the use of technology that connects different health care professionals to improve access to health care, including specialty care, for certain rural and medically underserved populations.  The bill explicitly adds dementia care to the types of specialty care that the program may address.

Bill· HRH.R. 5160 (119th)open

Stem Cell Therapeutic and Research Reauthorization Act of 2025

United States · United States Congress · 4 September 2025

Stem Cell Therapeutic and Research Reauthorization Act of 2025 This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA). The bill reauthorizes the C.W. Bill Young Cell Transplantation Program. This program supports transplantation of bone marrow and cord blood by increasing the quantities of donations, providing processes for matching and distributing donated materials to patients, and providing related information and research. Also, the bill reauthorizes and revises the National Cord Blood Inventory program, through which HRSA contracts with qualified cord blood banks to collect and maintain a supply of high-quality units for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill amends the inventory program by (1) changing the inventory goal from 150,000 units to a sufficient supply as determined by HRSA, (2) requiring HRSA to manage the size and composition of the inventory to maximize clinical utility and efficiency, and (3) defining high quality cord blood unit to mean a unit meeting current industry standards and the requirements of the Food and Drug Administration.

Bill· Wetgeving2025Z18750open

Amendment to the Act on the Professions in Individual Healthcare in connection with the inclusion of the acute care medical provider and the clinical physicist in the list of registered professions

Original: Wijziging van de Wet op de beroepen in de individuele gezondheidszorg in verband met het opnemen van de medisch hulpverlener acute zorg en de klinisch fysicus in de lijst van registerberoepen

Netherlands · House of Representatives · 5 October 2025

Translated from Dutch

Wijziging van de Wet op de beroepen in de individuele gezondheidszorg in verband met het opnemen van de medisch hulpverlener acute zorg en de klinisch fysicus in de lijst van registerberoepen

Bill· HRH.R. 2450 (119th)referred

Prescription Drug Transparency and Affordability Act

United States · United States Congress · 27 March 2025

Prescription Drug Transparency and Affordability Act This bill requires pharmacy benefit managers (PBMs) to report, at least once every six months, prescription drug pricing, payment, and utilization data to the health insurance plans for which the PBM provides services. Specifically, a PBM contracted to provide services to an employer or sponsor offering a large group health insurance plan (i.e., a plan with at least 100 employees or participants) must report to the plan certain information for prescription drug claims under the plan. This includes, for each drug, the difference between the compensation paid by the plan to the PBM and the compensation paid by the PBM to the pharmacy. Further, for each therapeutic class of drugs under the plan, a PBM must report (1) the total amount it received in rebates, fees, and discounts; and (2) the net spending for each class after such rebates, fees, and discounts. Each PBM also must report certain information about (1) drugs for which total spending exceeded $10,000; and (2) drugs dispensed through pharmacies affiliated with the plan or PBM, such as the percentage of prescriptions dispensed by such affiliates. Finally, a PBM providing services to any group health insurance plan must provide the plan with a summary document that includes similar information for prescription drug claims under the plan, as determined by the Department of Health and Human Services. Plans must also make certain aggregate summary information available to plan participants. PBMs and plans that violate these requirements are subject to civil penalties.

Bill· HRH.R. 4980 (119th)referred

BITE Act

United States · United States Congress · 15 August 2025

Bill· HRH.R. 1585 (119th)referred

Conrad State 30 and Physician Access Reauthorization Act

United States · United States Congress · 25 February 2025

Conrad State 30 and Physician Access Reauthorization Act This bill modifies the Conrad 30 Waiver program, which incentivizes qualified foreign physicians to serve in underserved communities. It also extends statutory authority for the program for three years from this bill's enactment. Individuals coming to the United States under a J-1 nonimmigrant visa to receive medical training typically must leave the country and reside for two years abroad before being eligible to apply for an immigrant visa or permanent residence. The Conrad program waives this requirement for individuals who meet certain qualifications, including serving for a number of years at a health care facility in an underserved area. The bill increases the number of waivers that a state may obtain each fiscal year from 30 to 35 if a certain number of waivers were used the previous year, and provides for further adjustments depending on demand. A physician may be employed at an academic medical center to meet the Conrad program's employment requirements if the physician's work is in the public interest, even if the medical center is not in an underserved area. Employment contracts for physicians under the Conrad program shall contain certain information, such as the maximum number of on-call hours per week the physician shall have to work. Certain physicians (along with the physician's spouse and children) shall be exempt from the direct annual numerical limits on immigration, including those physicians that have met certain requirements related to visas for physicians to serve in underserved areas.

Bill· HRH.R. 548 (119th)referred

HSA Modernization Act

United States · United States Congress · 16 January 2025

HSA Modernization Act This bill increases health savings account (HSA) contribution limits, expands HSA eligibility, and makes other changes to HSAs and high-deductible health plans (HDHP). The bill increases HSA contribution limits to equal the limits on out-of-pocket expenses under an HDHP (adjusted annually). Under the bill, the maximum annual HSA contribution for 2025 is $8,300 for self-only coverage and $16,600 for family coverage. (Under current law, the maximum annual HSA contribution for 2025 is $4,300 for self-only coverage and $8,550 for family coverage.) The bill expands eligibility to make tax-deductible HSA contributions to include individuals who receive hospital care or medical services from the Department of Veterans Affairs and do not have a service-connected disability, receive hospital care or medical services provided by the Indian Health Service or a tribal organization, are at least 65 years old and enrolled in Medicare Part A, or have a bronze-level or catastrophic health insurance plan through a health insurance exchange. The bill also allows eligible married individuals to make catch-up contributions to the same HSA. Under the bill, HSA distributions may be used to pay for qualified medical expenses incurred before the HSA is established if the HSA is established within 60 days from the first day of coverage under an HDHP. Further, the bill specifies that HSA distributions may be used to pay for expenses for qualified long-term care services. Finally, the bill allows an HDHP to provide up to $500 of mental health benefits before the annual deductible is met.

Bill· SS. 2426 (119th)referred

Equitable Community Access to Pharmacist Services Act

United States · United States Congress · 24 July 2025

Equitable Community Access to Pharmacist Services Act This bill provides for permanent coverage under Medicare of certain pharmacist services. Specifically, the bill provides for permanent coverage of testing and treatment services provided by pharmacists relating to (1) COVID-19, influenza, respiratory syncytial virus (RSV), and streptococcal pharyngitis (strep throat); and (2) other public health needs in relation to a declared public health emergency. (Similar authorities were temporarily granted during the COVID-19 public health emergency.) Such services must be provided in accordance with the applicable state laws governing pharmacists' scope of practice.

Bill· SS. 1816 (119th)referred

Improving Seniors’ Timely Access to Care Act of 2025

United States · United States Congress · 20 May 2025

Improving Seniors' Timely Access to Care Act of 2025 This bill establishes several requirements and standards relating to prior authorization processes under Medicare Advantage (MA) plans. Specifically, MA plans must (1) establish an electronic prior authorization program that meets specified standards; (2) annually submit to the CMS for publication specified prior authorization information, including the percentage of requests approved and the average response time; and (3) meet other standards, as set by the Centers for Medicare & Medicaid Services (CMS), relating to the quality and timeliness of prior authorization determinations. The CMS and the Office of the National Coordinator for Health Information Technology must publish on the CMS' website a report that analyzes the information received from MA plans, the feasibility of implementing real-time decision making with respect to prior authorization requests, and the impact of decisions that are made using artificial intelligence on patient access. 

Bill· HRH.R. 161 (119th)open

New Source Review Permitting Improvement Act

United States · United States Congress · 3 January 2025

New Source Review Permitting Improvement Act This bill modifies terminology for purposes of the New Source Review (NSR) permitting program of the Environmental Protection Agency (EPA). In order for a change to a stationary source to be a modification (a change to a stationary source that increases the air pollutant emissions or results in new pollutants) for purposes of the NSR permitting program, the maximum hourly emission rate achievable by such source must be higher than the maximum hourly rate achievable by such source during any hour in the 10-year period preceding the change. A change at a stationary source is not considered to be a modification under the bill if it is designed to (1) reduce the amount of any air pollutant emitted; or (2) restore, maintain, or improve the reliability of operations at, or safety of, the source. However, such changes are not excepted if the EPA determines the increase in the maximum achievable hourly emission rate from such change would cause an adverse effect on human health or the environment. Construction , in connection with a major emitting facility (a type of stationary source), does not include a change at such a facility that does not result in a significant emissions increase or a significant net emissions increase. In relation to major emitting facilities in nonattainment areas, the terms modifications and modified do not include changes at such facilities that do not result in a significant emissions increase or a significant net emissions increase.

Motion· Motie2025Z09354adopted

Motion by Member Van Nispen on algorithms that may use risk profiling and publish automated selection tools in the Algorithm Register

Original: Motie van het lid Van Nispen over algoritmes die mogelijk gebruikmaken van risicoprofilering en geautomatiseerde selectie-instrumenten in het Algoritmeregister publiceren

Netherlands · House of Representatives · 14 May 2025

Translated from Dutch

Motie van het lid Van Nispen over algoritmes die mogelijk gebruikmaken van risicoprofilering en geautomatiseerde selectie-instrumenten in het Algoritmeregister publiceren

Motion· Motie2025Z17268adopted

Amended motion by member Dassen about switching to European, open standards-based digital alternatives for the digital infrastructure for 36800-61

Original: Gewijzigde motie van het lid Dassen over overstappen op Europese, op open standaarden gebaseerde digitale alternatieven voor de digitale infrastructuur t.v.v. 36800-61

Netherlands · House of Representatives · 17 September 2025

Translated from Dutch

Gewijzigde motie van het lid Dassen over overstappen op Europese, op open standaarden gebaseerde digitale alternatieven voor de digitale infrastructuur t.v.v. 36800-61

Bill· HRH.R. 4611 (119th)referred

EACH Act of 2025

United States · United States Congress · 22 July 2025

Bill· HRH.R. 2199 (119th)referred

Restore Protections for Dialysis Patients Act

United States · United States Congress · 18 March 2025

Restore Protections for Dialysis Patients Act This bill specifies certain requirements for private health insurers regarding coverage of individuals with end stage renal disease (ESRD) who are also covered under Medicare.  In particular, the bill specifies that insurers may not limit benefits, including limiting network composition, in a manner that will affect ESRD Medicare beneficiaries differently compared to others without ESRD. The bill additionally specifies that insurers are not required to include a particular renal dialysis provider or a particular number of such providers as part of their networks. 

Bill· HRH.R. 5269 (119th)referred

RESULTS Act

United States · United States Congress · 10 September 2025

Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 or the RESULTS Act This bill requires the use of particular data from the private sector to inform Medicare payment rates for certain widely available laboratory tests.  Specifically, the Centers for Medicare & Medicaid Services (CMS) must contract with an entity that maintains a database of claims data for clinical diagnostic laboratory tests that (1) are not advanced diagnostic tests, and (2) were furnished by more than 100 providers and suppliers of such services over a specified six-month period (i.e., widely available tests). The database must meet specified requirements, such as having data that is representative of the entire country and from more than 50 private payors and claims administrators. The contracted entity must be a nonprofit entity that is not affiliated with any government agency, any insurance issuer or provider, or any other organization in the health care sector.  Beginning January 1, 2028, the CMS must use the information obtained from the database to inform Medicare payment rates for these widely available laboratory tests.  The bill additionally specifies processes for determining payment rates for laboratory tests that are not advanced diagnostic tests, are not widely available, and lack adequate claims data. The CMS must use certain existing processes to set appropriate rates. The bill also delays scheduled payment reductions for laboratory tests until 2028 and allows for judicial and administrative review of payment rates. 

Bill· HRH.R. 1532 (119th)referred

Scientific EXPERT Act of 2025

United States · United States Congress · 24 February 2025

Scientific External Process for Educated Review of Therapeutics Act of 2025 or the Scientific EXPERT Act of 2025 This bill requires the Food and Drug Administration (FDA) to facilitate and participate in externally led, science-focused drug development meetings to discuss the development of treatments for rare diseases and conditions.  The FDA must enter into an arrangement with the Reagan-Udall Foundation for the FDA under which the foundation agrees to convene such meetings. Meetings must be held at least four times a year, and each meeting must focus on a different rare disease or condition.  The foundation must establish a permanent steering committee to review and recommend topics for each meeting. In evaluating potential topics, the committee must consider unmet therapeutic needs, patient population sizes for different diseases and conditions, and whether a disease or condition would benefit from clarity and alignment on drug development questions, among other factors.  In planning each meeting, the foundation must develop a list of medical experts, drug sponsors, scientific organizations, patient organizations, and other entities to be invited to participate. Representatives of the FDA’s review divisions must attend each meeting.  After each meeting, the foundation must make available a summary of the meeting noting areas of consensus, areas where additional clarification or information is needed, and next steps agreed upon with the FDA. The bill also requires the FDA to indicate whether it incorporated any input from these meetings when approving a new drug or biologic. 

Bill· HRH.R. 4606 (119th)referred

Ally’s Act

United States · United States Congress · 22 July 2025

Bill· HRH.R. 210 (119th)open

Dental Care for Veterans Act

United States · United States Congress · 6 January 2025

Dental Care for Veterans Act This bill expands eligibility for veterans for dental care provided by the Department of Veterans Affairs (VA). Specifically, the bill makes all veterans who are enrolled in the VA health care system eligible for VA-provided dental services. Currently, only veterans who have a service-connected dental issue or meet other narrow criteria are eligible for certain dental services. The bill phases in eligibility over four years based upon existing eligibility, degree of service-connected disability or other disability, prisoner of war status, award of a Purple Heart, financial need, or VA health care eligibility.

Bill· HRH.R. 2120 (119th)referred

ROCR Value Based Program Act

United States · United States Congress · 14 March 2025

Radiation Oncology Case Rate Value Based Program Act of 2025 or the ROCR Value Based Program Act This bill establishes a specialized payment program under Medicare for providers and suppliers of radiation oncology services.  Specifically, the Centers for Medicare & Medicaid Services (CMS) must establish a program under which radiation therapy providers (i.e., hospital outpatient departments) and suppliers (i.e., physician group practices and freestanding radiation therapy centers) receive payments for each episode of care provided to individuals with specified types of cancer. An episode of care  means the period beginning on the day radiation therapy planning is furnished to the individual and ending (1) for individuals with bone or brain metastases, 30 days later; and (2) for individuals with other cancer types, 90 days later. Participation in the program is mandatory for providers and suppliers that participate in Medicare, unless the provider or supplier is part of a state-based Center for Medicare & Medicaid Innovation model or qualifies for a significant hardship exemption. The CMS must set payment rates for the program based on national payment rates with specified adjustments (e.g., geographic adjustments). Providers and suppliers who provide certain transportation services for individuals under their care may receive an additional payment. Providers and suppliers must be accredited in accordance with certain standards, subject to payment reductions. The Government Accountability Office must report on (1) implementation of the program, and (2) underserved areas that are in need of more or newer radiation therapy resources.

Bill· HRH.R. 1708 (119th)referred

Rebuild America’s Health Care Schools Act of 2025

United States · United States Congress · 27 February 2025

Rebuild America’s Health Care Schools Act of 2025 This bill allows hospitals to receive reimbursement under Medicare for certain costs associated with training nursing and allied health students in settings other than the hospital itself.  Currently, hospitals may receive reimbursement under Medicare for the reasonable costs associated with training nursing and allied health students if certain conditions are met; the criteria vary depending on whether the students are enrolled in an educational program that is operated by the hospital or another entity. If the students are part of a program that is operated by another entity, the training must occur at the hospital itself or in areas immediately surrounding the hospital in order to qualify for reimbursement (among other requirements). The bill allows hospitals to receive reimbursement for these costs if the training is conducted at an entity that is related to the hospital (i.e., common ownership or control). The bill requires the Centers for Medicare & Medicaid Services (CMS) to update regulations to reflect these changes. Additionally, the CMS may not recoup or reduce payments to hospitals with respect to costs that are allowed under the bill and must refund any such recoupments or reductions that occurred during the six-year period prior to the bill's enactment.

Bill· HRH.R. 3514 (119th)reported

Improving Seniors’ Timely Access to Care Act of 2025

United States · United States Congress · 20 May 2025

Improving Seniors' Timely Access to Care Act of 2025 This bill establishes several requirements and standards relating to prior authorization processes under Medicare Advantage (MA) plans. Specifically, MA plans must (1) establish an electronic prior authorization program that meets specified standards; (2) annually submit to the CMS for publication specified prior authorization information, including the percentage of requests approved and the average response time; and (3) meet other standards, as set by the Centers for Medicare & Medicaid Services (CMS), relating to the quality and timeliness of prior authorization determinations. The CMS and the Office of the National Coordinator for Health Information Technology must publish on the CMS' website a report that analyzes the information received from MA plans, the feasibility of implementing real-time decision making with respect to prior authorization requests, and the impact of decisions that are made using artificial intelligence on patient access. 

Bill· HRH.R. 3521 (119th)referred

Clinical Trial Modernization Act

United States · United States Congress · 20 May 2025

Clinical Trial Modernization Act This bill authorizes a grant program and provides certain exemptions to support the participation of individuals in clinical trials. Specifically, the bill authorizes a grant program to support outreach, education, and recruitment efforts for clinical trials that may benefit certain underrepresented populations or communities in need, such as rural or tribal areas. The bill also exempts from anti-kickback laws for federal health care programs (1) remuneration that is offered to cover participants' expenses to participate in clinical trials, (2) the provision of free digital health technologies to support participation of underrepresented populations in clinical trials, and (3) payment for participants' cost-sharing obligations in relation to clinical trials. Finally, the bill exempts up to $2,000 in remuneration that is received for participating in a clinical trial from income tax.

Bill· HRH.R. 2002 (119th)referred

MATCH IT Act of 2025

United States · United States Congress · 10 March 2025

Patient Matching And Transparency in Certified Health IT Act of 2025 or the MATCH IT Act of 2025 This bill requires the Department of Health and Human Services (HHS) to establish a definition and standards for patient matching (i.e., the process of accurately matching patients with their medical records, including when records are exchanged between health care providers). It also requires the development of (1) a minimum data set for technology standards to increase patient matching, and (2) incentives for patient matching under Medicare. Specifically, the bill requires HHS to develop a uniform definition and standards for patient matching to track patient match rates and document improvement over time. The definition and standards must account for certain situations, including duplicate records and multiple matches. The bill also requires the Office of the National Coordinator for Health Information Technology (ONC) to adopt a minimum data set to help health care providers or health information systems achieve a patient match rate of 99.9%. The minimum data set and related standards must be incorporated into the U.S. Core Data for Interoperability and the Medicare Promoting Interoperability Program for health information technology. Additionally, the Centers for Medicare & Medicaid Services (CMS) must establish a voluntary bonus measure within the Medicare Promoting Interoperability Program to allow health care providers who have a patient match rate over a certain percentage to receive a payment adjustment. The ONC and CMS must develop a voluntary reporting program for providers to anonymously submit patient matching data to HHS. 

Bill· HRH.R. 1966 (119th)referred

Mamas and Babies in Underserved Communities Act of 2025

United States · United States Congress · 6 March 2025

Mamas and Babies in Underserved Communities Act of 2025 This bill establishes Department of Health and Human Services grants for public or nonprofit private health care providers to expand and improve maternal health care services (including prenatal, postnatal, and postpartum care) and reduce disparities in access to such care. Health care providers are eligible to apply if they serve one or more minority, low-income, or medically underserved communities.

Page 1 of 75Next

Documents

Files attached to records under this subject. Downloads fetch the official source on click; nothing is stored here.

Page 1 of 289Next